HEPA
Hepion Pharmaceuticals, Inc.
-0.01 (-9.42%)0.06USD12成交股數5.6M市值0.1本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 51K | 70K | – | – | 423K | 22K | 2.8M | 7.1M | 2.5M | 5.4M | 8.5M | 11.9M |
| 銷售管理費用 | 1.2M | 729K | 610K | 528K | 919K | 1.3M | 1.7M | 1.4M | 2.6M | 1.8M | 2.1M | 2.3M |
| 營業利益 | −1.2M-31% | −799K-38% | −610K-86% | −528K-94% | −1.7M-66% | −1.3M-88% | −4.5M-58% | −8.5M-40% | −5.2M | −10.4M | −10.7M | −14.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −1.2M+20% | −811K-87% | −657K-87% | −473K-88% | −1.0M-63% | −6.1M-45% | −4.9M-54% | −3.9M-72% | −2.9M | −11.1M | −10.5M | −14.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.08-11% | -0.07-97% | 1.40-104% | -0.04-100% | -0.09-100% | -2.15-100% | -36.21+1222% | -34.00+824% | -28.13 | -606.17 | -2.74 | -3.68 |
| 稀釋股數 | 16.2M | 11.6M | 9.4M | 11.6M | 11.3M | 2.8M | 134K | 116K | 101K | 79.4K | 3.8M | 3.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.6M | 2.6M | 1.8M | 2.3M | 2.9M | 4.6M | 1.5M | 2.1M | 13.1M | 14.8M | 19.3M | 30.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.9M | 2.7M | 3.1M | 3.7M | 4.5M | 6.3M | 3.7M | 6.0M | 16.0M | 18.1M | 25.0M | 36.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 649K | 849K | 402K | 416K | 709K | 2.4M | 4.1M | 2.4M | 8.5M | 10.8M | 8.8M | 10.1M |
| 股東權益 | 1.3M | 1.9M | 2.7M | 3.3M | 3.8M | 3.9M | 407K | 3.6M | 7.5M | 7.3M | 16.2M | 26.4M |
| 負債比 | 33.7% | 31.4% | 13.1% | 11.1% | 15.7% | 38.3% | 110.9% | 40.7% | 53.0% | 59.8% | 35.4% | 27.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 579K-152% | – | – | – | −1.1M | – | – | −3.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 31K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.3M | –% | -0.88 | – |
| FY2024 | – | – | −13.2M | –% | -107.35 | – |
| FY2023 | 0 | – | −48.9M | –% | -616.07 | −40.9M |
| FY2022 | 0 | – | −42.2M | –% | -11.90 | −35.0M |
| FY2021 | 0 | – | −32.7M | –% | -0.47 | −31.4M |
| FY2020 | 0 | – | −20.4M | –% | -2.10 | −16.3M |
| FY2019 | – | – | −7.0M | –% | -6.11 | −7.6M |
| FY2018 | – | – | −9.4M | –% | -1.39 | – |